Trial intelligence / Profile preview

RAPS Trial: Pre-operative Radiation and Microbubble CEUS in Early-stage ER+ Breast Cancer

NCT06444269Phase 2Recruiting

Sponsor
UT Southwestern Medical Center
Start
Oct 2024
Primary completion
Jul 2027
Countries
1
01

Overview

Phase 2, open-label trial in breast cancer (2 cohorts), sponsored by UT Southwestern Medical Center. Primary endpoint: Single fraction pre-operative radiation at 4 years. Started Oct 2024; status: recruiting.

02

Conditions

breast cancer

Beyond the preview

Go deeper on NCT06444269.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT06444269.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call